Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19

被引:0
|
作者
Morteza Gholaminejhad
Mehdi Forouzesh
Babak Ebrahimi
Seyed Amirhosein Mahdavi
Seyed Davood Mirtorabi
Amirreza Liaghat
Seyed Jalil Monabati
Muhammad Obaid Hamza
Gholamreza Hassanzadeh
机构
[1] Legal Medicine Organization,Legal Medicine Research Center
[2] Tehran University of Medical Sciences,Department of Anatomy, School of Medicine
[3] Legal Medicine Research Center,Department of Medical Laboratory Techniques, College of Medical Technical
[4] Legal Medicine Organization,Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine
[5] Al-Farahidi University,undefined
[6] Tehran University of Medical Sciences,undefined
来源
关键词
COVID-19; NLRP3; Inflammasome; Lung; Histopathology; Coronavirus;
D O I
暂无
中图分类号
学科分类号
摘要
COVID-19 is a contagious disease that attacks many organs but the lungs are the main organs affected. The inflammasome activation results in the exacerbation of inflammatory response in infectious disease. The aim of this study is to investigate the formation and activity of the NLRP3 inflammasome complex and the histopathological changes caused by the coronavirus in the lung of deceased persons with COVID-19. In total, 10 corpses; 5 corpses with no history of any infectious diseases and COVID-19 and 5 corpses with the cause of death of COVID-19 were included in this study. Lung tissue samples were harvested during autopsy under safe conditions. Fresh tissues in each group were used to measure the genes expression and proteins level of NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α and a routine hematoxylin and eosin staining was performed for histological assessment. Data are represented as the means ± SD. Statistical significance difference was accepted at a p-value less than 5%. The NLRP3, ASC, Caspase-1, IL-1β, IL-6 and TNF-α genes expression and proteins level were elevated in the lung of the COVID-19 group in comparison with the control group. Histological findings presented the increasing number of polymorphonuclear leukocytes, macrophages and also pulmonary fibrosis in the lungs of corpses with the cause of death of COVID-19. High expression of NLRP3 inflammasome components and its relation with the pathophysiology of the coronavirus-infected lung suggested that targeting the NLRP3 inflammasome could be helpful in achieving a more effective treatment in patients with COVID-19.
引用
收藏
页码:883 / 890
页数:7
相关论文
共 50 条
  • [1] Formation and activity of NLRP3 inflammasome and histopathological changes in the lung of corpses with COVID-19
    Gholaminejhad, Morteza
    Forouzesh, Mehdi
    Ebrahimi, Babak
    Mahdavi, Seyed Amirhosein
    Mirtorabi, Seyed Davood
    Liaghat, Amirreza
    Monabati, Seyed Jalil
    Hamza, Muhammad Obaid
    Hassanzadeh, Gholamreza
    JOURNAL OF MOLECULAR HISTOLOGY, 2022, 53 (06) : 883 - 890
  • [2] Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
    Zhang, Jiayu
    Ma, Xuejing
    Liu, Fuwei
    Zhang, Deju
    Ling, Jitao
    Zhu, Zicheng
    Chen, Yixuan
    Yang, Pingping
    Yang, Yanlin
    Liu, Xiao
    Zhang, Jing
    Liu, Jianping
    Yu, Peng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] NLRP3, the inflammasome and COVID-19 infection
    Donnelly, Seamas C.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2023, 116 (07) : 477 - 477
  • [4] Severe COVID-19: NLRP3 Inflammasome Dysregulated
    van den Berg, Daan F.
    te Velde, Anje A.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [5] Targeting the NLRP3 Inflammasome in Severe COVID-19
    Freeman, Tracey L.
    Swartz, Talia H.
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [6] Targeting autophagy regulation in NLRP3 inflammasome-mediated lung inflammation in COVID-19
    Yong, Yuan-Yuan
    Zhang, Li
    Hu, Yu-Jiao
    Wu, Jian-Ming
    Yan, Lu
    Pan, Yi-Ru
    Tang, Yong
    Yu, Lu
    Law, Betty Yuen-Kwan
    Yu, Chong-Lin
    Zhou, Jie
    Li, Mao
    Qin, Da-Lian
    Zhou, Xiao-Gang
    Wu, An-Guo
    CLINICAL IMMUNOLOGY, 2022, 244
  • [7] Common NLRP3 inflammasome inhibitors and Covid-19: Divide and conquer
    Batiha, Gaber El-Saber
    Al-Gareeb, Ali I.
    Rotimi, Damilare
    Adeyemi, Oluyomi Stephen
    Al-kuraishy, Hayder M.
    SCIENTIFIC AFRICAN, 2022, 18
  • [8] NLRP3 Inflammasome: The Stormy Link Between Obesity and COVID-19
    Lopez-Reyes, Alberto
    Martinez-Armenta, Carlos
    Espinosa-Velazquez, Rocio
    Vazquez-Cardenas, Paola
    Cruz-Ramos, Marlid
    Palacios-Gonzalez, Berenice
    Gomez-Quiroz, Luis Enrique
    Martinez-Nava, Gabriela Angelica
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [9] Colchicine reduces the activation of NLRP3 inflammasome in COVID-19 patients
    Amaral, N. B.
    Rodrigues, T. S.
    Giannini, M. C.
    Lopes, M. I.
    Bonjorno, L. P.
    Menezes, P. I. S. O.
    Dib, S. M.
    Gigante, S. L. G.
    Benatti, M. N.
    Rezek, U. C.
    Emrich-Filho, L. L.
    Sousa, B. A.
    Almeida, S. C. L.
    Luppino-Assad, R.
    Veras, F. P.
    Schneider, A. H.
    Leiria, L. O. S.
    Cunha, L. D.
    Alves-Filho, J. C.
    Cunha, T. M.
    Arruda, E.
    Miranda, C. H.
    Pazin-Filho, A.
    Auxiliadora-Martins, M.
    Borges, M. C.
    Fonseca, B. A. L.
    Bollela, V. R.
    Del-Ben, C. M.
    Cunha, F. Q.
    Santana, R. C.
    Vilar, F. C.
    Zamboni, D. S.
    Louzada-Junior, P.
    Oliveira, R. D. R.
    INFLAMMATION RESEARCH, 2023, 72 (05) : 895 - 899
  • [10] Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation
    Bonaventura, Aldo
    Vecchie, Alessandra
    Dagna, Lorenzo
    Tangianu, Flavio
    Abbate, Antonio
    Dentali, Francesco
    INFLAMMATION RESEARCH, 2022, 71 (03) : 293 - 307